Recent studies have shown that T lymphocytes can be redirected against cancer cell lines using CEA as a target antigen through the use of CIRs expressed in T cells isolated from healthy donors (Nolan et al, 1999; Beecham et al, 2000; Daly et al, 2000; Hombach et al, 2000). Here, CEACAM5 is linked to cancer.